Evidence map›Paper›PMID 41516254›Full record

ReviewInternational journal of molecular sciences2025

AI-Driven Digital Pathology: Deep Learning and Multimodal Integration for Precision Oncology.

Hyun-Jong Jang, Sung Hak Lee

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hyun-Jong JangDepartment of Physiology, CMC Institute for Basic Medical Science, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.ORCID 0000-0003-4535-1560
Sung Hak LeeDepartment of Hospital Pathology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.ORCID 0000-0003-1020-5838

Funding

Korea Health Industry Development Institute RS-2021-KH113146
6 · The paper itself

Abstract

Pathology is fundamental to precision oncology, offering molecular and morphologic insights that enable personalized diagnosis and treatment. Recently, deep learning has demonstrated substantial potential in digital pathology, effectively addressing a wide range of diagnostic, prognostic, and biomarker-prediction tasks. Although early approaches based on convolutional neural networks had limited capacity to generalize across tasks and datasets, transformer-based foundation models have substantially advanced the field by enabling scalable representation learning, enhancing cross-cohort robustness, and supporting few- and even zero-shot inference across a wide range of pathology applications. Furthermore, the ability of foundation models to integrate heterogeneous data within a unified processing framework broadens the possibility of developing more generalizable models for medicine. These multimodal foundation models can accelerate the advancement of pathology-based precision oncology by enabling coherent interpretation of histopathology together with radiology, clinical text, and molecular data, thereby supporting more accurate diagnosis, prognostication, and therapeutic decision-making. In this review, we provide a concise overview of these advances and examine how foundation models are driving the ongoing evolution of pathology-based precision oncology.

Indexed as

Artificial IntelligenceDeep LearningMedical OncologyNeoplasmsPrecision MedicineConvolutional Neural NetworksHumansartificial intelligencedeep learningdigital pathologyfoundation modelprecision oncologyradiology

Identifiers

PMID41516254
PMCPMC12785522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.